Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of pH on the Formation of Acylated Octreotides by Poly(lactide-co-glycolide)

  • Received : 2010.07.20
  • Accepted : 2010.07.29
  • Published : 2010.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

The formation of acylated peptide impurities in poly(lactide-co-glycolide) (PLGA) formulations is one of the major challenges to the development of successful sustained-release product. Octreotide, synthetic analogue of somatostatin, has been identified to be acylated in PLGA microsphere formulations. The purpose of this study was to investigate the pH effect on the formation of acylated octreotides by PLGA. In the incubation with PLGA in 0.1 M phosphate buffer at pH 7.4, approximately 98% of octreotide adsorbed to PLGA through 14 days and 66.3% of acylated octreotides were produced after 42 days, whereas the interaction of octreotide with PLGA was significantly inhibited in the incubation at pH 4, in which the acylated octreotides were observed to be 9.2% after 42 days. In the interaction study at pH 4.1-7.4, the production of acylated octreotides was demonstrated to be dependent on environmental pH. Below pH 5.0, the acylation of octreotide was significantly inhibited. This study indicates that the pH is the major factor for the formation of acylated octreotide in PLGA formulations.

Keywords

References

  1. Anderson, J.M., Shive, M.S., 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev 28, 5-24. https://doi.org/10.1016/S0169-409X(97)00048-3
  2. Bilati, U., Allemann, E., Doelker, E., 2005. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm 59, 375-388. https://doi.org/10.1016/j.ejpb.2004.10.006
  3. Chen, F., O'Dorisio, M.S., Hermann, G., Hayes, J., Malarkey, W.B., O'Dorisio, T.M., 1993. Mechanisms of action of long-acting analogs of somatostatin, Regul. Pept 44, 285-295. https://doi.org/10.1016/0167-0115(93)90138-X
  4. Gombotz, W.R., Pettit, D.K., 1995. Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem 6, 332-351. https://doi.org/10.1021/bc00034a002
  5. Houchin, M.L., Heppert, K., Topp, E.M., 2006. Deamidation, acylation and proteolysis of a model peptide in PLGA films. J. Control. Release 112, 111-119. https://doi.org/10.1016/j.jconrel.2006.01.018
  6. Lucke, A., Kiermaier, J., Gopferich, A., 2002. Peptide acylation by poly(alpha-hydroxy esters). Pharm. Res 19, 175-181. https://doi.org/10.1023/A:1014272816454
  7. Murty, S.B., Thanoo, B.C., Wei, Q., DeLuca, P.P., 2005a. Impurity formation studies with peptide-loaded polymeric microspheres: Part I. In vivo evaluation. Int. J. Pharm 297, 50-61. https://doi.org/10.1016/j.ijpharm.2005.02.035
  8. Murty, S.B., Na, D.H., Thanoo, B.C., DeLuca, P.P., 2005b. Impurity formation studies with peptide-loaded polymeric microspheres: Part II. In vitro evaluation. Int. J. Pharm 297, 62-72. https://doi.org/10.1016/j.ijpharm.2005.02.034
  9. Na, D.H., Youn, Y.S., Lee, S.D., Son, M.W., Kim, W.B., DeLuca, P.P., Lee, K.C., 2003. Monitoring of peptide acylation inside degrading PLGA microspheres by capillary electrophoresis and MALDI-TOF mass spectrometry. J. Control. Release 92, 291-299. https://doi.org/10.1016/S0168-3659(03)00366-3
  10. Na, D.H., DeLuca, P.P., 2005. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide). Pharm. Res 22, 736-742. https://doi.org/10.1007/s11095-005-2589-4
  11. Na, D.H., Lee, J.E., Jang, S.W., Lee, K.C., 2007. Formation of acylated growth hormone-releasing peptide-6 by poly(lactide-coglycolide) and its biological activity. AAPS PharmSciTech 8, article 43.
  12. Ryu, K.W., Na, D.H., 2009. Stability of octreotide acetate in aqueous solutions and PLGA films. J. Kor. Pharm. Sci 39, 353-357. https://doi.org/10.4333/KPS.2009.39.5.353
  13. Sinha, V.R., Trehan, A., 2005. Biodegradable microspheres for parenteral delivery. Crit. Rev. Ther. Drug Carrier Syst 22, 535-602. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v22.i6.20
  14. Van de Weert, M., Hennink, W.E., Jiskoot, W., 2000. Protein instability in poly(lactic-co-glycolic acid) microparticles, Pharm. Res 17, 1159-1167. https://doi.org/10.1023/A:1026498209874
  15. Wischke, C., Schwendeman, S.P., 2008. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm 364, 298-327. https://doi.org/10.1016/j.ijpharm.2008.04.042

Cited by

  1. Reversible Blocking of Amino Groups of Octreotide for the Inhibition of Formation of Acylated Peptide Impurities in Poly(Lactide-co-Glycolide) Delivery Systems vol.12, pp.4, 2011, https://doi.org/10.1208/s12249-011-9694-y